JRCT ID: jRCTs061180031
Registered date:27/02/2019
The efficacy of Daikenchuto(TJ-100) on abdominal pain and abdominal fullness feeling in the patients with fecal incontinence.
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Abdominal pain and abdominal fullness feeling in the patients with fecal incontinence |
Date of first enrollment | 09/12/2017 |
Target sample size | 50 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Daikenchuto (15g/day) for 4 weeks |
Outcome(s)
Primary Outcome | Abdominal pain and abdominal fullness feeling |
---|---|
Secondary Outcome | the severity of fecal incontinence (Wexner score, Japanese version) QOL of fecal incontinence (Fecal incontinence quality of life scales, Japanese version) anorectal manometry (resting period or contracting period) number of fecal incontinence, number of defecation stool form (Bristol Stool Form Scale) |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Patients who have faecal incontinence of 2-4 times/4 weeks or more in the past 6 months Patients who have abdominal pain or abdominal fullness feeling Age: Aged 20 and over Mini Mental State Examination (MMSE) over 11 Patients for whom oral administration was possible Patients who provided written informed consent regarding study participation |
Exclude criteria | Patients who have anal sphincter injury Patients who have severe mental illness Patients who can not perform their daily activities Suspected organic disease such as the cancer in gastrointestinal tract Presence of serious complications (liver, kidney, heart, or blood disease or metabolic disease) Patients who took drugs prohibited for concomitant use 2 weeks before entry. History of allergic reactions to Kampo medicines Pregnant or lactating women or those who are planning to conceive during the study period Considered ineligible to participate by principal investigator or sub-investigator |
Related Information
Primary Sponsor | Shimazutsu Kazufumi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Tsumura & Co. |
Secondary ID(s) | UMIN000030252 |
Contact
Public contact | |
Name | Kazufumi Shimazutsu |
Address | 8-29-24 Nishihara, Asaminami-ku, Hiroshima, Hiroshima 731-0113, JAPAN Hiroshima Japan 731-0113 |
Telephone | +81-82-850-3116 |
stratmagic@mac.com | |
Affiliation | Medical Corporation Seiaikai, Gion Ushita Hospital |
Scientific contact | |
Name | Kazufumi Shimazutsu |
Address | 8-29-24 Nishihara, Asaminami-ku, Hiroshima, Hiroshima 731-0113, JAPAN Hiroshima Japan 731-0113 |
Telephone | +81-82-850-3116 |
stratmagic@mac.com | |
Affiliation | Medical Corporation Seiaikai, Gion Ushita Hospital |